Craft

Ambu

Stock Price

KR136.6

2024-06-21

Market Capitalization

KR36.4 B

2024-06-21

Revenue

KR4.8 B

FY, 2023

Ambu Summary

Company Summary

Overview
Ambu is a company that provides healthcare solutions in the fields of anesthesia, patient monitoring and diagnostics, and emergency care. It offers bronchoscopes, rhinolaryngoscopes, rhinolaryngoscopes, gastroscopes, cystoscopes, displaying and processing units (aView and aBox), mobile workstations (aCart), video laryngoscopes, laryngeal and face masks, resuscitators, double lumen and single lumen tubes, endobronchial blockers, electrodes, electromyography (EMG) guided injections, intraoperative monitoring, training manikins, etc.
Type
Public
Status
Active
Founded
1937
HQ
Ballerup, DK | view all locations
Website
https://www.ambu.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Britt Meelby Jensen
  • Thomas Schmidt

    Thomas Schmidt, Executive Vice President, CFO

  • Måns Barsne

    Måns Barsne, Executive Vice President and Chief Innovation Officer

  • Jakob Koch

    Jakob Koch, Director, Intellectual Property

Operating MetricsView all

Units Sold

1.7M

FY, 2022

LocationsView all

25 locations detected

  • Ballerup HQ

    Denmark

    Baltorpbakken 13

  • Columbia, MD

    United States

    6721 Columbia Gateway Dr #200

  • Noblesville, IN

    United States

    15011 Herriman Blvd

  • Warriewood, NSW

    Australia

    5/2 Daydream St

  • Bruxelles, Bruxelles

    Belgium

    Rue de la Presse 4

  • Shanghai, Shang Hai Shi

    China

    Room 1710, 17th Floor, No. 450 Caoyang Rd Pu Tuo District

and 19 others

Ambu Financials

Summary Financials

Revenue (Q2, 2024)
kr1.4B
Gross profit (Q2, 2024)
kr904.0M
Net income (Q2, 2024)
kr144.0M
Cash (Q2, 2024)
kr387.0M
EBIT (Q2, 2024)
kr194.0M
Enterprise value
$36.7B

Footer menu